financetom
Business
financetom
/
Business
/
Lancaster Colony Insider Bought Shares Worth $507,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lancaster Colony Insider Bought Shares Worth $507,000, According to a Recent SEC Filing
Aug 29, 2024 8:17 AM

10:06 AM EDT, 08/29/2024 (MT Newswires) -- Elliot K. Fullen, Director, on August 27, 2024, executed a purchase for 3,000 shares in Lancaster Colony ( LANC ) for $507,000. Following the Form 4 filing with the SEC, Fullen has control over a total of 5,298 shares of the company, with 5,298 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/57515/000122520824008293/xslF345X05/doc4.xml

Price: 170.13, Change: +1.26, Percent Change: +0.75

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aclaris Therapeutics Signs License Agreement with Chinese Biotech Biosion
Aclaris Therapeutics Signs License Agreement with Chinese Biotech Biosion
Nov 19, 2024
09:43 AM EST, 11/18/2024 (MT Newswires) -- Aclaris Therapeutics ( ACRS ) said Monday that it has acquired global development rights outside of China for potential anti-TSLP monoclonal and bispecific antibodies directed against both TSLP and IL4R developed by Chinese biotech firm Biosion. The license agreement states that Biosion will receive more than $40 million in cash from Aclaris as...
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
Nov 19, 2024
* Lower court found Norwich generic infringes Salix patents * Alvogen has Xifaxan generic deals with Teva, Sun, Sandoz By Blake Brittain WASHINGTON, Nov 18 (Reuters) - The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version of Canada-based Bausch Health's ( BHC ) blockbuster diarrhea drug Xifaxan. The justices...
--Trump Team Looking to Ease Rules on Self-Driving Cars, Bloomberg Reports
--Trump Team Looking to Ease Rules on Self-Driving Cars, Bloomberg Reports
Nov 19, 2024
09:40 AM EST, 11/18/2024 (MT Newswires) -- Price: 343.84, Change: +23.12, Percent Change: +7.21 ...
Brazil development bank signs deal with AIIB for nearly $3 billion in investments
Brazil development bank signs deal with AIIB for nearly $3 billion in investments
Nov 19, 2024
(Reuters) - Brazilian development bank BNDES said on Monday that it has signed a deal with the Asian Infrastructure Investment Bank (AIIB) for the investment of 16.7 billion reais ($2.89 billion) in Latin America's largest economy. The deal, which was signed on the sidelines of the G20 summit in Rio de Janeiro, is aimed at funding projects aligned with Brazil's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved